Summary of the Twenty-ninth International Symposium on Amyotrophic Lateral Sclerosis-Motor Neuron Disease
10.3760/cma.j.issn.1006-7876.2019.10.014
- VernacularTitle: 第29届国际肌萎缩侧索硬化-运动神经元病会议简介
- Author:
Xusheng HUANG
1
;
Liying CUI
2
;
Dongsheng FAN
3
;
Xiaoguang LI
2
;
Mingsheng LIU
2
;
Huifang SHANG
4
;
Xiaoli YAO
5
;
Jiahong LU
6
;
Min ZHANG
7
;
Yan CHEN
6
;
Qi NIU
8
;
Xueping CHEN
4
Author Information
1. Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China
2. Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
3. Department of Neurology, the Third Hospital of Peking University, Beijing 100191, China
4. Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China
5. Department of Neurology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510089, China
6. Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
7. Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
8. Department of Geriatric Neurology, Jiangsu Province Hospital, Nanjing 210029, China
- Publication Type:Journal Article
- Keywords:
Amyotrophic lateral sclerosis;
Motor neuron disease;
Congresses
- From:
Chinese Journal of Neurology
2019;52(10):866-871
- CountryChina
- Language:Chinese
-
Abstract:
The 29th International Symposium on Amyotrophic Lateral Sclerosis (ALS)-Motor Neuron Disease was held in Glasgow from December 7 to 9, 2018. The symposium was divided into 23 topics, with 109 special reports and paper′s exchange and 515 posters exchange. This article briefly introduces some topics of the symposium, involving basic researches, clinical researches and clinical trials. Among these, basic researches include genetics and genomics, axonal degeneration, disease models, and preclinical therapeutic strategies; Clinical researches include epidemiology, clinical progression, cognitive and psychological change, neuropathology, neurophysiology, neuroimaging and biomarkers.
